Cahira Technologies is positioned at the speculative frontier of nanoelectronic neural interfaces, proposing self-deploying, non-surgical implants that bypass traditional neurosurgical constraints entirely. This approach, if technically viable, would represent a step-change relative to both intracortical and endovascular BCIs, though the company remains at a highly conceptual preclinical stage with significant unanswered questions around targeting precision, safety, and regulatory feasibility.